PRESS RELEASE published on 11/08/2023 at 18:05, 1 year ago EQS-Adhoc: EVN AG: EVN increases outlook for Group net result in 2022/23
PRESS RELEASE published on 10/05/2023 at 12:00, 1 year 1 month ago EVN AG: EVN Capital Markets Day 2023: Extensive information for investors and analysts
PRESS RELEASE published on 09/18/2023 at 09:26, 1 year 2 months ago EQS-Adhoc: EVN AG: EVN decides to commence a structured bidder process for WTE
PRESS RELEASE published on 08/24/2023 at 07:30, 1 year 2 months ago EVN AG: Business development in the first three quarters of 2022/23
PRESS RELEASE published on 06/19/2023 at 17:57, 1 year 5 months ago EVN AG: Changes on the Supervisory Board and Executive Board of EVN AG
PRESS RELEASE published on 06/19/2023 at 16:35, 1 year 5 months ago EQS-Adhoc: EVN AG: Early termination of appointment of the member of the executive board Franz Mittermayer; invitation to apply for nomination will be issued
PRESS RELEASE published on 05/25/2023 at 07:30, 1 year 5 months ago EVN AG: Business development in the first half of 2022/23
PRESS RELEASE published on 05/15/2023 at 18:52, 1 year 6 months ago EQS-Adhoc: EVN AG: The management board proposes the distribution of a special dividend for the 2022/23 financial year and specifies expected Group net result for 2022/23
PRESS RELEASE published on 04/11/2023 at 18:32, 1 year 7 months ago EQS-Adhoc: EVN AG: Chairwoman of the supervisory board resigns
PRESS RELEASE published on 02/21/2023 at 07:30, 1 year 9 months ago EVN AG: Business development in the first quarter of 2022/23
Published on 11/21/2024 at 13:30, 11 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 11 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 41 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 41 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 41 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 6 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 26 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 43 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 21 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 19 hours 56 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 19 hours 56 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 5 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
